Study of D-2570 with other drugs in healthy adults
This study checks how a new medicine, D-2570, interacts with other drugs in healthy adults. It helps find the right dose and safety before it is tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are a healthy adult, with no major medical conditions.
- Your weight is at least 50 kg (men) or 45 kg (women), and your body mass index (BMI) is between 19 and 26.
- You agree to use effective birth control or abstain from sex from screening until 30 days after the last dose.
- You have no history of shingles or severe cold sores, and you are not afraid of needles or blood.
- You have not had surgery that could affect how your body absorbs medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
This trial tests how a drug called D-2570 is processed in people with different levels of liver function. It compares people with liver impairment to those with healthy livers to see how the drug moves through the body.
This study tests how a new drug, D-2570, is processed by the body in people with normal or reduced kidney function. It aims to understand if kidney function affects how the drug works, which could help guide dosing.
This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.